Back to News
Market Impact: 0.65

Rivian's Path To Profitability Gets Longer As Regulatory Changes Squeeze Margins

RIVNJPMTSLAVWAGY
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsCompany FundamentalsAutomotive & EVRegulation & LegislationTax & Tariffs
Rivian's Path To Profitability Gets Longer As Regulatory Changes Squeeze Margins

Rivian shares fell 3% after its Q2 results showed a wider-than-expected adjusted EPS loss of $0.97 and an adjusted EBITDA loss of $667 million, despite revenue slightly beating estimates at $1.303 billion. The company significantly downgraded its full-year profitability outlook, now expecting breakeven gross profit and a wider adjusted EBITDA loss of -$2.0 billion to -$2.25 billion, largely due to regulatory changes impacting credit revenue and higher fixed costs. This prompted analysts to cut price targets, with JPMorgan reiterating an Underweight rating due to concerns over deeper losses, weak execution, and projected substantial free cash outflow, while Wedbush maintained Outperform but lowered its target.

Analysis

Rivian's second-quarter results reveal a significant deterioration in its profitability profile and outlook, overshadowing a modest revenue beat. While revenue increased 5.1% year-over-year to $1.303 billion, the adjusted EPS loss of 97 cents was substantially wider than the 76 cents consensus, signaling persistent cost pressures. The core issue is margin collapse; adjusted gross margin plummeted to 4.9% from 26.5% in the prior quarter, and core automotive gross margin, excluding credits, fell to a staggering -36% according to JPMorgan. This profitability challenge is compounded by a sharply downgraded full-year forecast. Rivian now expects breakeven gross profit, a stark reduction from its prior $300 million projection, attributing the change primarily to the loss of an anticipated $160 million in high-margin regulatory credits due to legislative changes. Consequently, the adjusted EBITDA loss guidance has worsened to a range of -$2.0 to -$2.25 billion. This has prompted divergent but generally cautious analyst responses, with JPMorgan reiterating an Underweight rating and a $9 price target, citing weak execution and a projected $2.8 billion free cash outflow for 2025. In contrast, Wedbush maintained an Outperform rating but cut its price target to $16, viewing the current issues as near-term hurdles in a longer-term transformation. A key mitigating factor is the company’s liquidity, which remains robust at $7.5 billion in cash, supplemented by expected inflows from Volkswagen and government loans.